{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:21:33Z","timestamp":1786123293396,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1213\/ane.0b013e31825b6fb2","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T03:29:13Z","timestamp":1336706953000},"page":"1155-1161","source":"Crossref","is-referenced-by-count":16,"title":["Use of Analgesic, Anesthetic, and Sedative Medications During Pediatric Hospitalizations in the United States 2008"],"prefix":"10.1213","volume":"115","author":[{"given":"Tamar","family":"Lasky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank R.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210902","doi-asserted-by":"crossref","first-page":"F448","DOI":"10.1136\/adc.2005.082263","article-title":"Pharmacological therapy for analgesia and sedation in the newborn.","volume":"91","author":"Anand","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R2-22-20210902","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pcl.2005.09.008","article-title":"Pediatric procedural sedation and analgesia.","volume":"53","author":"Doyle","year":"2006","journal-title":"Pediatr Clin North Am"},{"key":"R3-22-20210902","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(06)68230-5","article-title":"Procedural sedation and analgesia in children.","volume":"367","author":"Krauss","year":"2006","journal-title":"Lancet"},{"key":"R4-22-20210902","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pds.2063","article-title":"Estimating pediatric inpatient medication use in the United States.","volume":"20","author":"Lasky","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R5-22-20210902","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/pch\/12.2.95","article-title":"Why were we abandoned Orphan drugs in paediatric pain.","volume":"12","author":"Gregoire","year":"2007","journal-title":"Paediatr Child Health"},{"key":"R6-22-20210902","first-page":"343","article-title":"Off-label medication use in an academic hospital pediatric critical care unit.","volume":"108","author":"Hsu","year":"2009","journal-title":"WMJ"},{"key":"R7-22-20210902","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpedi.161.3.282","article-title":"Off-label drug use in hospitalized children.","volume":"161","author":"Shah","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R8-22-20210902","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/PCC.0b013e3181fe25b9","article-title":"Food and Drug Administration approval for medications used in the pediatric intensive care unit: a continuing conundrum.","volume":"12","author":"Yang","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R9-22-20210902","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpeds.2007.07.050","article-title":"Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.","volume":"152","author":"Kumar","year":"2008","journal-title":"J Pediatr"},{"key":"R10-22-20210902","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clinthera.2009.02.003","article-title":"Estimates of pediatric medication use in the United States: current abilities and limitations.","volume":"31","author":"Lasky","year":"2009","journal-title":"Clin Ther"},{"key":"R12-22-20210902","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.clinthera.2011.05.090","article-title":"Impact of drug label changes on propofol use in pediatrics for moderate conscious sedation.","volume":"33","author":"Heaton","year":"2011","journal-title":"Clin Ther"},{"key":"R13-22-20210902","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/01.inf.0000101846.83256.5a","article-title":"The march toward rational therapeutics in children.","volume":"22","author":"Gorman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R14-22-20210902","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00008480-199504000-00014","article-title":"Status of drug approval processes and regulation of medications for children.","volume":"7","author":"Kauffman","year":"1995","journal-title":"Curr Opin Pediatr"},{"key":"R15-22-20210902","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jama.290.7.905","article-title":"Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.","volume":"290","author":"Roberts","year":"2003","journal-title":"JAMA"},{"key":"R16-22-20210902","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJMhpr021646","article-title":"Testing medications in children.","volume":"347","author":"Steinbrook","year":"2002","journal-title":"N Engl J Med"},{"key":"R17-22-20210902","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.clinthera.2006.09.007","article-title":"Criteria supporting the study of drugs in the newborn.","volume":"28","author":"Ward","year":"2006","journal-title":"Clin Ther"},{"key":"R18-22-20210902","doi-asserted-by":"crossref","first-page":"313106","DOI":"10.1371\/journal.pone.0013106","article-title":"Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published in 1948-2006.","volume":"5","author":"Thomson","year":"2010","journal-title":"PLoS One"},{"key":"R19-22-20210902","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1542\/peds.2008-0585","article-title":"Safety monitoring of drugs receiving pediatric marketing exclusivity.","volume":"122","author":"Smith","year":"2008","journal-title":"Pediatrics"},{"key":"R20-22-20210902","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/qshc.2006.019950","article-title":"Medication errors in paediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations.","volume":"16","author":"Miller","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"R23-22-20210902","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJMra012626","article-title":"Analgesics for the treatment of pain in children.","volume":"347","author":"Berde","year":"2002","journal-title":"N Engl J Med"},{"key":"R25-22-20210902","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1001\/jama.290.18.2464","article-title":"Current status of pain management in children.","volume":"290","author":"Howard","year":"2003","journal-title":"JAMA"},{"key":"R26-22-20210902","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1460-9592.2009.03113.x","article-title":"Moral responsibility to attain thorough pediatric drug labeling.","volume":"19","author":"Waisel","year":"2009","journal-title":"Pediatr Anesth"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e31825b6fb2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:18:38Z","timestamp":1786112318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201211000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e31825b6fb2","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}